Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02464904 · ClinicalTrials.gov registry record · NA
Intrapleural Cryotherapy for Malignant Pleural Mesothelioma
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT02464904: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT02464904 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02464904, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
Can neoadjuvant intrapleural cryotherapy be safely performed in patients with malignant pleural mesothelioma and will it trigger substantial systemic and local pro-inflammatory changes, resulting in the induction of anti-tumor immunity?
Interventions
- OTHER Control
- PROCEDURE Cryotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2015-07 |
| Est. Completion | 2021-02-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02464904
The ClinicalTrials.gov registry entry for NCT02464904 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT02464904 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02464904 about?
NCT02464904 is a clinical study titled "Intrapleural Cryotherapy for Malignant Pleural Mesothelioma". Can neoadjuvant intrapleural cryotherapy be safely performed in patients with malignant pleural mesothelioma and will it trigger substantial systemic and local pro-inflammatory changes, resulting in the induction of anti-tumor immunity?
What is the current status of trial NCT02464904?
This trial is currently terminated. It is a NA study. The enrollment target is 17 participants. The study started on 2015-07. Estimated completion is 2021-02-26.
What interventions are being tested in trial NCT02464904?
The interventions under investigation include: Control (OTHER), Cryotherapy (PROCEDURE).
Who is sponsoring clinical trial NCT02464904?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.